title: The role of the N-terminus of mammalian copper transporter 1 in the cellular accumulation of cisplatin.
abstract: The mammalian copper transporter 1 (CTR1) is responsible for the uptake of copper (Cu) from the extracellular space, and has been shown to play a major role in the initial accumulation of platinum-based drugs. In this study we re-expressed wild type and structural variants of hCTR1 in mouse embryo fibroblasts in which both alleles of mCTR1 had been knocked out (CTR1(-/-)) to examine the role of the N-terminal extracellular domain of hCTR1 in the accumulation of cisplatin (cDDP). Deletion of either the first 45 amino acids or just the (40)MXXM(45) motif in the N-terminal domain did not alter subcellular distribution or the amount of protein in the plasma membrane but it eliminated the ability of hCTR1 to mediate the uptake of Cu. In contrast it only partially reduced cDDP transport capacity. Neither of these structural changes prevented cDDP from triggering the rapid degradation of hCTR1. However, they did alter the potency of the cDDP that achieved cell entry, possibly reflecting the fact that hCTR1 may mediate the transport of cDDP both through the pore it forms in the plasma membrane and via endocytosis. We conclude that cDDP interacts with hCTR1 both at (40)MXXM(45) and at sites outside the N-terminal domain that produce the conformational changes that trigger degradation.
authors.affiliation: Moores Cancer Center and Department of Medicine, University of California, San Diego, La Jolla, 92093, United States. calarson@ucsd.edu
authors.forename: Christopher A
authors.initials: CA
authors.lastname: Larson
authors.forename: Preston L
authors.initials: PL
authors.lastname: Adams
authors.forename: Danielle D
authors.initials: DD
authors.lastname: Jandial
authors.forename: Brian G
authors.initials: BG
authors.lastname: Blair
authors.forename: Roohangiz
authors.initials: R
authors.lastname: Safaei
authors.forename: Stephen B
authors.initials: SB
authors.lastname: Howell
mesh_terms: D000818:Animals; D001692:Biological Transport / Q000187:drug effects* / Q000502:physiology; D027682:Cation Transport Proteins / Q000737:chemistry / Q000502:physiology*; D002460:Cell Line; D002478:Cells, Cultured / Q000378:metabolism*; D002945:Cisplatin / Q000493:pharmacokinetics*; D003300:Copper / Q000494:pharmacology; D000079923:Copper Transporter 1; D019008:Drug Resistance, Neoplasm / Q000187:drug effects; D006801:Humans; D051379:Mice
chemical_list: D027682:Cation Transport Proteins; D000079923:Copper Transporter 1; D003300:Copper; D002945:Cisplatin
references.citation: Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14298-302
references.pmid: 12370430
references.citation: J Inorg Biochem. 2004 Oct;98(10):1607-13
references.pmid: 15458823
references.citation: Proc Natl Acad Sci U S A. 2003 Feb 4;100(3):1215-20
references.pmid: 12538877
references.citation: Clin Cancer Res. 2004 Oct 1;10(19):6744-9
references.pmid: 15475465
references.citation: Clin Cancer Res. 2009 Jan 15;15(2):553-60
references.pmid: 19147760
references.citation: J Natl Cancer Inst. 1991 Jun 5;83(11):757-66
references.pmid: 2041050
references.citation: Mol Pharmacol. 2009 Oct;76(4):843-53
references.pmid: 19570948
references.citation: J Biol Chem. 2002 Jul 19;277(29):26021-30
references.pmid: 11983704
references.citation: Clin Cancer Res. 2009 Jul 1;15(13):4312-21
references.pmid: 19509135
references.citation: Proc Natl Acad Sci U S A. 2001 Jun 5;98(12):6842-7
references.pmid: 11391005
references.citation: Proc Natl Acad Sci U S A. 2009 Mar 17;106(11):4237-42
references.pmid: 19240214
references.citation: J Biol Chem. 2004 Apr 23;279(17):17428-33
references.pmid: 14976198
references.citation: Mol Pharmacol. 2006 Oct;70(4):1390-4
references.pmid: 16847145
references.citation: J Nutr Biochem. 2004 Jun;15(6):316-22
references.pmid: 15157936
references.citation: J Biol Inorg Chem. 2009 Nov;14(8):1313-23
references.pmid: 19669174
references.citation: Nat Chem Biol. 2008 Mar;4(3):176-85
references.pmid: 18277979
references.citation: J Biol Chem. 2002 Oct 25;277(43):40253-9
references.pmid: 12177073
references.citation: Biometals. 2007 Jun;20(3-4):705-16
references.pmid: 17211682
references.citation: Mol Pharmacol. 2009 Feb;75(2):324-30
references.pmid: 18996970
references.citation: Biochem J. 2008 Feb 1;409(3):731-40
references.pmid: 17944601
references.citation: Eur J Cancer. 2002 Jul;38(10):1405-12
references.pmid: 12091073
references.citation: Mol Cancer Ther. 2004 Dec;3(12):1543-9
references.pmid: 15634647
references.citation: Mol Pharmacol. 2010 Jun;77(6):887-94
references.pmid: 20159940
references.citation: Angew Chem Int Ed Engl. 2007;46(47):9062-4
references.pmid: 17886318
references.citation: J Biol Chem. 2004 Dec 17;279(51):53435-41
references.pmid: 15385536
references.citation: J Biol Inorg Chem. 2009 Feb;14(2):163-5
references.pmid: 19034536
references.citation: J Biol Chem. 2005 Nov 4;280(44):37159-68
references.pmid: 16135512
references.citation: Gene. 2000 Aug 22;254(1-2):87-96
references.pmid: 10974539
references.citation: Cancer Res. 2006 Nov 15;66(22):10944-52
references.pmid: 17108132
references.citation: Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3627-32
references.pmid: 16501047
references.citation: J Histochem Cytochem. 2006 Sep;54(9):1041-9
references.pmid: 16709730
references.citation: EMBO J. 1996 Nov 15;15(22):6084-95
references.pmid: 8947031
references.citation: Proc Natl Acad Sci U S A. 2001 Jun 5;98(12):6836-41
references.pmid: 11391004
references.citation: J Am Chem Soc. 2009 Oct 14;131(40):14196-7
references.pmid: 19807176
references.citation: Curr Opin Gastroenterol. 2007 Mar;23(2):187-92
references.pmid: 17268249
references.citation: Biochim Biophys Acta. 2006 Jul;1763(7):737-46
references.pmid: 16784785
references.citation: J Biol Chem. 2002 Aug 9;277(32):29162-71
references.pmid: 12034741
references.citation: J Biol Chem. 2007 Sep 14;282(37):26775-26785
references.pmid: 17627943